The Mprize for longevity science was mentioned in the press a few times in recent days. Here are a couple of the articles.
“The idea that was capturing me,” Dave Gobel, the Mprize’s founder, told me, “is that nothing seems to have been cured since polio … I began to ask what was the reason for that.”
Mice are genetically similar to humans and, if not tampered with, they don’t live long. Bartke got his up to 1,819 days – your average mouse would be lucky to make it to 750 days – by knocking out its growth hormone receptor gene. Don’t try this at home just yet.
The Mprize agenda [is] highly ideological. It is based on a belief that it is not only possible but also good to work to extend human life, to make us, ultimately, medically immortal. This is not a goal that either governments or companies could explicitly embrace – too weird, too risky, too controversial – but a prize can make it work.
In October, Sharp also accepted the prestigious Mprize Lifespan Achievement Award in New York City from the Methuselah Foundation for his research finding. The foundation is named for the biblical figure who lived to be 969 years.
“Aging research has finally come of age,” says Arlan G. Richardson, director of the Barshop Institute. “Recognition as one of the top scientific discoveries in 2009 by Science magazine is a major honor for our institution, for Randy and Dave, and for the field of aging. To my knowledge, this is the first aging-related discovery to be recognized as one of the top scientific discoveries by the research community.”